Aurora Cannabis Inc. (ACB) vs Lexeo Therapeutics, Inc. Common Stock (LXEO)

A side-by-side comparison of Aurora Cannabis Inc. and Lexeo Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aurora Cannabis Inc. logo
ACB
Aurora Cannabis Inc.
$281M
$4.54HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Lexeo Therapeutics, Inc. Common Stock logo
LXEO
Lexeo Therapeutics, Inc. Common Stock
$259M
$3.30HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — ACB vs LXEO

growth of $100 · dividends reinvested · last 3y
ACB -1.5% (-0.5%/yr)LXEO -66.1% (-30.3%/yr)ACB compounded faster over this window
50100150200Start $100202420252026$98$34
ACB LXEO

ACB vs LXEO: by the numbers

  • •ACB is the larger company ($281M vs $259M market cap).
  • •Both run net losses; LXEO's is the smaller (0.00% vs -38.13% net margin).

Metrics side by side

Valuation

MetricACBLXEO
P/S ratio1.35N/A
P/B ratio0.761.10

Profitability

MetricACBLXEO
Gross margin42.62%0.00%
Operating margin-14.55%0.00%
Net margin-38.13%0.00%
ROE-21.41%-37.12%
ROIC-15.69%-39.76%

Growth (annualized)

MetricACBLXEO
Revenue CAGR (5Y)1.68%N/A
Total return CAGR (5Y)-42.83%N/A

Go deeper

Full ACB analysisFull LXEO analysisInteractive comparison tool

Dig into the metrics

Aurora Cannabis ROELexeo Therapeutics, Inc. Common Stock ROEAurora Cannabis operating marginLexeo Therapeutics, Inc. Common Stock operating marginAurora Cannabis revenue growthLexeo Therapeutics, Inc. Common Stock revenue growthAurora Cannabis free cash flowLexeo Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.